(RTTNews) - Lyell Immunopharma, Inc. (LYEL), a clinical-stage biotechnology company, is scheduled to present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15 ...
Lyell Immunopharma (LYEL) has been beaten down lately with too much selling pressure. While the stock has lost 31.2% over the past four weeks, there is light at the end of the tunnel as it is now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback